Order results by:
| Issue | Title | |
| Vol 8, No 6 (2012) | THE EFFECT OF MAGNESIUM DRUGS ON THE PHYSICAL PERFORMANCE OF YOUNG PEOPLE WITH MITRAL VALVE PROLAPSE: RESULTS OF NONCOMPARATIVE STUDY | Abstract similar documents |
| K. M. Dzeranova, A. G. Avtandilov, N. V. Vertkina | ||
| "... Aim. To study the dynamics of physical performance in young people with mitral valve prolapse (MVP ..." | ||
| Vol 9, No 4 (2013) | EFFECT OF MAGNESIUM OROTATE ON CONNECTIVE TISSUE MATRIX AND CARDIAC INOTROPIC FUNCTION IN PATIENTS WITH MITRAL VALVE PROLAPSE. CLINICAL AND MORPHOLOGICAL STUDY | Abstract similar documents |
| A. G. Avtandilov, K. M. Dzeranova, T. G. Borovaya, L. V. Didenko | ||
| "... contractility in patients with mitral valve prolapse before and after magnesium orotate course. Material ..." | ||
| Vol 3, No 3 (2007) | COMPARATIVE EFFECTS OF MONOTHERAPY WITH MAGNESIUM AND COMBINED THERAPY WITH MAGNESIUM AND Β-BLOCKER ON PRIMARY MITRAL VALVE PROLAPSE WITH HEART RHYTHM DISORDERS | Abstract similar documents |
| E. G. Nurtdinova, A. N. Zakirova, T. B. Khairetdinova | ||
| "... -blocker on primary mitral valve prolapse (MVP) with heart rhythm disorders. Material and methods. 71 ..." | ||
| Vol 6, No 5 (2010) | MAGNESIUM AND MITRAL VALVE PROLAPSE. EFFICACY AND THE POINTS OF APPLICATION | Abstract similar documents |
| A. G. Avtandilov, K. M. Dzeranova, A. A. Pukhaeva, E. D. Manizer | ||
| "... Mitral valve prolapse (MVP) is a manifestation of the hereditary syndrome of differentiated ..." | ||
| Vol 8, No 4 (2012) | MAGNESIUM IN CLINICAL PRACTICE | Abstract similar documents |
| E. L. Trisvetova | ||
| "... the effectiveness of magnesium orotate for many cardiovascular diseases. ..." | ||
| Vol 10, No 1 (2014) | MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT | Abstract similar documents |
| E. I. Trisvetova | ||
| "... of magnesium deficiency is realized using magnesium-containing drugs, for example magnesium orotate, having ..." | ||
| Vol 4, No 5 (2008) | MOLECULAR MECHANISMS OF ACTION OF MAGNESIUM OROTATE ON CARDIOVASCULAR SYSTEM | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova | ||
| "... of orotic acid and magnesium orotate on cardiovascular system as well as therapeutic implementation ..." | ||
| Vol 11, No 2 (2015) | MORPHOFUNCTIONAL CHARACTERISTICS OF FIBROBLASTS (MCCOY CELL LINE) CULTURED WITH MAGNESIUM PREPARATIONS | Abstract similar documents |
| L. V. Didenko, T. G. Borovaya, E. A. Kost, E. A. Ulubieva, A. V. Timofeeva, A. G. Avtandilov | ||
| "... Aim. To study the effect of magnesium orotate, magnesium/pyridoxine combination and magnesium ..." | ||
| Vol 13, No 1 (2017) | CHANGE IN CONTENT OF GLYCOPROTEINS ON THE SURFACE OF ENDOTHELIAL CELL CULTURE EA.HY 926 AND INTIMA OF INTERNAL CAROTID ARTERIES UNDER THE INFLUENCE OF MAGNESIUM OROTATE | Abstract similar documents |
| L. V. Didenko, E. A. Ulubieva, T. G. Borovaya, A. G. Avtandilov, N. V. Shevlyagina, V. G. Zhukhovitsky, O. M. Grinkevich, M. V. Mezentseva | ||
| "... the influence of magnesium orotate. Material and methods. Endotheliocytes of cell culture EA.hy 926 were ..." | ||
| Vol 12, No 1 (2016) | Effect of magnesium on the cardiovascular system in women | Abstract PDF (Eng) similar documents |
| E. A. Ulubieva, A. G. Avtandilov | ||
| "... Обобщены современные научные данные последних лет о влиянии магния на сердечно-сосудистую ..." | ||
| Vol 7, No 4 (2011) | FOCUS ON MAGNESIUM BASED DRUGS | Abstract similar documents |
| I. I. Esenova | ||
| "... В современном мире недостаток магния в организме является одним из наиболее часто встречающихся ..." | ||
| Vol 8, No 3 (2012) | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... эффективность препаратов магния при различных патологических состояниях системы кровообращения. Физиологическое ..." | ||
| Vol 5, No 5 (2009) | EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE | Abstract PDF (Eng) similar documents |
| V. N. Larina, B. Y. Bart, M. P. Mikhaylusova, B. N. Mamtsev | ||
| "... in patients with functional mitral regurgitation (MR) of various degrees. Material and methods. A total ..." | ||
| Vol 6, No 4 (2010) | DIAGNOSTICS AND TREATMENT OF MITRAL VALVE PROLAPSE | Abstract similar documents |
| D. A. Kuzhel, G. V. Matyushin, E. A. Savchenko | ||
| "... The mitral valve prolapse (MVP) is one of the most inconsistent diagnose. In the most cases ..." | ||
| Vol 19, No 1 (2023) | Arrhythmic Mitral Valve Prolapse: New Menaces of the Known Disease | Abstract similar documents |
| D. A. Kuzhel, G. V. Matyushin, E. A. Savchenko | ||
| "... Mitral valve prolapse (MVP) has long been the subject of intense discussions regarding ..." | ||
| Vol 7, No 4 (2011) | CLINICAL IMPORTANCE OF IDIOPATHIC MITRAL ANNULAR CALCIFICATION | Abstract similar documents |
| N. S. Chipigina, G. M. Urvacheva, N. A. Shostak | ||
| "... Idiopathic mitral annular calcification (MAC) — pathological states that diagnosed mostly often ..." | ||
| Vol 5, No 1 (2009) | ECHOCARDIOGRAPHIC AND LABORATORY MARKERS OF CHRONIC HEART FAILURE: WHETHER IT IS POSSIBLE TO USE THEM IN RHEUMATIC MITRAL DISEASES? | Abstract similar documents |
| T. A. Kazakovtseva, N. A. Shostak | ||
| "... ) natriuretic peptides, in patients with mitral heart diseases of rheumatic aetiology. Material and methods ..." | ||
| Vol 7, No 6 (2011) | MITRAL ANNULAR CALCIFICATION IN ELDERLY PATIENTS. CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS | Abstract similar documents |
| N. S. Chipigina, G. M. Urvacheva, N. A. Shostak, I. V. Zhitareva, I. Yu. Zhitomirskaya | ||
| "... Background. The clinical significance of idiopathic mitral annular calcification (MAC) often ..." | ||
| Vol 20, No 2 (2024) | Risk factors of ventricular arrhythmias in non-syndromic mitral valve prolapse | Abstract similar documents |
| E. L. Trisvetova | ||
| "... Non-syndromic mitral valve prolapse (MVP) is a common disease. In most cases, its benign course ..." | ||
| Vol 4, No 1 (2008) | TISSUE DOPPLEROGRAPHY IN EARLY DIAGNOSIS OF FUNCTIONAL MYOCARDIAL DISORDERS IN ARTERIAL HYPERTENSION | Abstract similar documents |
| Y. A. Vasyuk, A. B. Hadzegova, S. V. Ivanova, E. N. Yuschuk, I. M. Amirbegishvili, N. I. Gerasimova | ||
| "... - and Doppler-echocardiography of transmitral blood flow, TDG of mitral annulus, determination of blood level ..." | ||
| Vol 16, No 3 (2020) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2) | Abstract similar documents |
| A. S. Safaryan, V. S. Sargsyan, D. V. Nebieridze | ||
| "... Статья посвящена влиянию магния на гомеостаз организма и, в частности, на сердечно-сосудистую ..." | ||
| Vol 15, No 5 (2019) | The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 1) | Abstract similar documents |
| A. S. Safaryan, V. S. Sargsyan, T. V. Kamyshova, N. M. Akhmedzhanov, D. V. Nebieridze, E. A. Poddubskaya | ||
| "... Статья посвящена влиянию магния на гомеостаз организма и, в частности, на сердечно-сосудистую ..." | ||
| Vol 6, No 5 (2010) | POTASSIUM AND MAGNESIUM DRUGS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN THE PRACTICE OF PRIMARY CARE PHYSICIAN | Abstract similar documents |
| A. M. Shilov, M. V. Melnik, A. O. Osiya, A. S. Lishuta | ||
| "... Обсуждается роль дефицита магния и калия в развитии сердечно-сосудистых заболеваний и их ..." | ||
| Vol 21, No 2 (2025) | Replenishment of intracellular magnesium deficiency in cardiac arrhythmias: focus on the physicochemical properties of complex compounds | Abstract similar documents |
| Ya. G. Bozhko, N. A. Belokonova, O. M. Medvedeva, K. A. Butova, M. V. Arkhipov | ||
| "... Цель. На основе оценки физико-химических свойств комплексных соединений магния и экспериментов с ..." | ||
| Vol 15, No 6 (2019) | Study of the Effect of Proton Pump Inhibitors on the Development of Hypomagnesemia in Patients with Paroxysmal Atrial Fibrillation on the Background of Autonomic Sinus Node Dysfunction | Abstract similar documents |
| Ya. G. Bozhko, M. V. Arkhipov, N. A. Belokonova | ||
| "... .51 [0.45-0.59] mmol/l vs 0.48 [0.44-0.51] mmol/l, p=0.04). To substantiate the observed effects ..." | ||
| Vol 18, No 6 (2022) | The Effect of Angiotensin Receptor and Neprilysin Inhibitors on Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction and Functional Mitral Regurgitation | Abstract similar documents |
| A. S. Ryazanov, E. V. Shikh, O. V. Kechina, M. V. Makarovskaya, A. A. Kudryavtsev | ||
| "... parameters in patients with chronic heart failure (CHF) and functional mitral regurgitation (FMR) under ..." | ||
| Vol 3, No 5 (2007) | TISSUE DOPPLER IMAGING OF LONGITUDINAL MOVEMENT OF A FIBROUS RING OF MITRAL VALVE DURING ISOVOLUMIC PERIODS IN LEFT VENTRICULAR HYPERTROPHY | Abstract similar documents |
| B. Amarjagal, S. B. Tkachenko, N. A. Mazur, N. F. Beresten | ||
| "... of mitral valve (MFR) during isovolumic contraction (IVC) and relaxation (IVR) in hypertensive patients ..." | ||
| Vol 6, No 4 (2010) | MAGNESIUM METABOLISM AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. V. Yezhov, L. T. Pimenov, M. A. Makarova, T. V. Savelyev | ||
| "... обмена магния у больных ишемической болезнью сердца (ИБС). Материал и методы. В исследование включены ..." | ||
| Vol 9, No 1 (2013) | FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY | Abstract PDF (Eng) similar documents |
| V. N. Larina, B. Ya. Bart, E. A. Vartanyan | ||
| "... .001), III-IV degree mitral regurgitation (p=0.007), hyperuricemia (p<0.001), lower exercise tolerance (p=0 ..." | ||
| Vol 6, No 3 (2010) | IS THERE AN ALTERNATIVE TO EJECTION FRACTION IN INSTRUMENTAL EVALUATION OF CHRONIC HEART FAILURE SEVERITY IN POST-MYOCARDIAL INFARCTION PATIENTS? | Abstract similar documents |
| T. A. Kazakovtseva, N. A. Shostak | ||
| "... of LV isovolumic contraction and relaxation, Е/А ratio for mitral flow, grade of valvular regurgitation ..." | ||
| Vol 18, No 6 (2022) | A Case Report of Differential Diagnosis of Causes of Severe Valvular Heart Disease (Takayasu's Arteritis, Infective Endocarditis and Myxomatous Degeneration) with the Key Role of Histological and PCR Examination | Abstract similar documents |
| A. S. Pisaryuk, E. O. Kotova, P. V. Ageev, A. Yu. Moiseeva, N. M. Povalyaev, E. A. Domonova, O. Yu. Silveistrova, N. S. Tsimbalist, Ju. I. Babukhina, I. A. Meray, P. V. Kakhktsyan, A. D. Meshkov, A. F. Safarova, Zh. D. Kobalava | ||
| "... lesion due to the myxomatous degeneration of the aortic and mitral valves associated with development ..." | ||
| Vol 8, No 2 (2012) | ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... безопасности различных лекарственных форм АСК. Гидроокись магния, входящая в комбинированный препарат ..." | ||
| Vol 9, No 4 (2013) | EFFECTS OF TRIMETAZIDINE ON THE TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE | Abstract similar documents |
| Yu. N. Fedulaev, N. S. Pavlyuchenko, T. V. Pinchuk, S. Kh. Galachieva, A. A. Kozina, V. N. Ryzhenkov | ||
| "... only standard therapy. Echocardiographic parameters, including mitral Doppler flow indices were ..." | ||
| Vol 16, No 1 (2020) | Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report) | Abstract similar documents |
| N. T. Vatutin, G. G. Taradin, G. A. Ignatenko, E. S. Gasendich, A. V. Harchenko, I. B. Povaljaeva | ||
| "... in the efficacy of warfarin in a patient with mitral stenosis while taking a combined choleretic drug is presented ..." | ||
| Vol 10, No 3 (2014) | EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... velocity at the fibrous ring of the mitral valve (p<0.001). The correlation between systolic velocity ..." | ||
| Vol 12, No 5 (2016) | Hypertrophic Cardiomyopathy and Connective Tissue Dysplasia Syndrome: Comorbidity Variants | Abstract similar documents |
| Yu. N. Belenkov, E. V. Privalova, V. Yu. Kaplunova, I. S. Chekneva, Yu. I. Najmann, M. V. Kozhevnikova, G. A. Shakaryants, A. S. Lishuta | ||
| "... was found in 17% of patients (mitral valve prolapse – 6.3%, tricuspid valve prolapse – 2.7%, supplemental ..." | ||
| Vol 7, No 1 (2011) | RESPIRATORY FUNCTION IN PATIENTS WITH RHEUMATIC HEART DISEASE COMPLICATED WITH PULMONARY HYPERTENSION | Abstract similar documents |
| N. A. Shostak, A. A. Klimenko, I. A. Novikov | ||
| "... . Patients (n=56; 4 men and 52 women; aged 63,25±7,93) with rheumatic combined mitral and aortic valvular ..." | ||
| Vol 20, No 1 (2024) | Clinical, electrical, and functional changes following CRT-P implantation: short-term results in patients with non-ischaemic cardiomyopathy | Abstract PDF (Eng) similar documents |
| S. A. Mostafa, A. М. Abdelmoneim, H. Ramadan, E. S. Elkeshk | ||
| "... diastolic and systolic volume, LVEDV and LVESV), mitral regurgitation (degree of mitral regurgitation ..." | ||
| Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
| "... in group A1 with type 2 and type 3 of LV remodeling reduced less (2%, p=0.02 and 4%, p=0.04, respectively ..." | ||
| Vol 6, No 3 (2010) | THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| V. I. Podzolkov, A. E. Bragina, Ju. N. Rodionova, E. K. Panferova | ||
| "... , respectively, р=0,03). Negative relations between aldosterone and estradiol levels (r=-0,3; p=0,04 ..." | ||
| Vol 15, No 2 (2019) | Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko | ||
| "... of the mitral valve in comparison with the reference level was found in 21 (36%) VLC patients with ascites ..." | ||
| Vol 17, No 4 (2021) | Evaluation of the Influence of CYP2C9* 2, CYP2C9*3 Gene Polymorphisms on the Efficacy and Safety of Postoperative Analgesia with Ketoprofen in Patients after Cardiac Surgery | Abstract similar documents |
| T. E. Morozova, D. A. Shatsky, N. V. Shikh, E. V. Shikh, T. B. Andrushchyshina, M. V. Lukina, A. A. Kachanova, Zh. A. Sozaeva, G. N. Shuev, N. P. Denisenko, E. A. Grishina, D. A. Sychev | ||
| "... ] (р=0,04), 6 [5; 7] vs 5 [4; 5] (р=0,04), 5 [3; 6] vs 3 [3; 4] points (р=0,02) on days 1, 2, 3 and 5 ..." | ||
| Vol 12, No 6 (2016) | EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... negative peak (Em) in the mitral valve fibrous ring and increased viral load (r=0.31; p<0.05), as well ..." | ||
| Vol 17, No 3 (2021) | Heart Condition in Convalescents of Hemorrhagic Fever with Renal Syndrome According to Echocardiography Data | Abstract similar documents |
| K. M. Manakhov, O. E. Tsarenko, O. N. Chevplyanskaya, L. I. Bagautdinova, A. V. Melnikov, O. V. Malinin, M. V. Dudarev, D. S. Sarksyan, A. E. Platonov, V. V. Maleev | ||
| "... with diastolic left ventricle filling by the type of relaxation violation in 8 (29.6%) cases. Mitral valve ..." | ||
| Vol 5, No 3 (2009) | EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION | Abstract similar documents |
| K. G. Adamyan, A. L. Chilingarian | ||
| "... additional differences appeared (midwall fractional shortening; E/Em of lateral mitral annulus – 8,6±4 ..." | ||
| Vol 13, No 5 (2017) | LEFT ATRIAL FUNCTION: MODERN ASSESSMENT METHODS AND CLINICAL SIGNIFICANCE | Abstract similar documents |
| E. N. Pavlyukova, D. A. Kuzhel, G. V. Matyushin | ||
| "... , thus without mitral valve disease LA expanding is a sign of LV filling pressure augmentation ..." | ||
| Vol 11, No 3 (2015) | IMPACT OF THE ANTIVIRAL THERAPY ON CARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Goncharova, E. V. Radaeva | ||
| "... at fibrous ring of mitral valve and high viral load. Strong correlation (r=0.81; p<0.05) was also found ..." | ||
| Vol 16, No 1 (2020) | Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice | Abstract similar documents |
| A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko | ||
| "... of 62.55±11.12 years. Exclusion criteria were mitral stenosis, mechanic prosthetic valve, first episode ..." | ||
| Vol 15, No 1 (2019) | Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City | Abstract similar documents |
| A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich | ||
| "... , mitral stenosis. The diagnosis of AF was established in accordance with the current recommendations. All ..." | ||
| Vol 15, No 4 (2019) | Atrial Septal Aneurysm in Adult Patients of Therapeutic Hospital | Abstract similar documents |
| O. V. Ryazantseva, N. I. Lenkova, O. D. Ostroumova, E. V. Shikh, S. M. Rykova | ||
| "... ). Undifferentiated connective tissue dysplasia was diagnosed in 14 (93.3%) ASA patients. Prolapse of mitral (60 ..." | ||
| Vol 17, No 3 (2021) | Assesment of Markers of Endothelial Dysfunction and Myocardial Stress in Patients with Hypertrophic Cardyomyopathy | Abstract similar documents |
| F. M. Bogatyreva, V. Yu. Kaplunova, M. V. Kozhevnikova, G. A. Shakaryants, D. A. Yatsenko, А. V. Emelianov, A. S. Lishuta, N. V. Khabarova, E. V. Privalova, Yu. N. Belenkov | ||
| "... thickness and the level of NT-proBNP (r=0.30; p=0.04). A correlation was found between the level of the vWF ..." | ||
| Vol 12, No 3 (2016) | ESTIMATION OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN DIFFERENT AGE GROUPS | Abstract PDF (Eng) similar documents |
| R. A. Gajfulin, A. N. Sumin, O. G. Arhipov | ||
| "... correlated with age: At (p=0.004); Et/At (p=0.001); Vpt (p=0.002) and e't/a't ratio (p=0.004). Conclusion ..." | ||
| Vol 7, No 3 (2011) | EFFECT OF THERAPEUTIC TRAINING AND ACTIVE OUTPATIENT MANAGEMENT ON CLINICAL STATE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE (THREE YEAR FOLLOW-UP) | Abstract similar documents |
| A. P. Rebrov, N. A. Kosheleva | ||
| "... conventionally managed. Kaplan-Meier curves revealed that risk of CHF decompensation (р=0.001), mortality (р=0.04 ..." | ||
| Vol 16, No 3 (2020) | The Short-Term Effect of Stent Size and Number on Left Ventricular Systolic Function Improvement After Elective Percutaneous Coronary Intervention | Abstract PDF (Eng) similar documents |
| Sh. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk | ||
| "... (p=0.001), and a number of stents (p=0.04). There was strong negative correlation between stent ..." | ||
| Vol 14, No 6 (2018) | Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety | Abstract PDF (Eng) similar documents |
| N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov | ||
| "... safety criteria is [0,02-0,38] for QT prolongation and [-0,04-0,04] for bradycardia. Conclusion. Safety ..." | ||
| Vol 17, No 5 (2021) | Pharmacogenetic Aspects of Postoperative Anesthesia with Ketoprofen in Cardiac Surgery Patients | Abstract similar documents |
| T. E. Morozova, D. A. Shatsky, N. V. Shikh, E. V. Shikh, T. B. Andrushchyshina, M. V. Lukina, A. A. Kachanova, Z. A. Sozaeva, G. N. Shuev, N. P. Denisenko, E. А. Grishina, D. A. Sychev | ||
| "... ,8 points (p=0,04), 3,52±1,95 and 4,5±1,7 points (p=0,04) in patients with GA and GG genotypes on days 4 ..." | ||
| Vol 21, No 1 (2025) | Correction of anemia using an iron supplement with a hepcidin-independent absorption mechanism in patients with chronic heart failure with preserved left ventricular ejection fraction | Abstract similar documents |
| A. A. Gurkina, N. I. Stuklov, V. A. Kokorin, R. R. Gimadiev, N. V. Varekha | ||
| "... .05, and serum ferritin increased from 106 (40-181) μg/L to 117 (83-166) μg/L, p = 0.04. N-terminal natriuretic ..." | ||
| Vol 19, No 4 (2023) | Predictors of recurrent cardiovascular events in patients with a single-vessel coronary artery disease after ST-segment elevation myocardial infarction | Abstract similar documents |
| V. E. Oleynikov, E. V. Averyanova, A. A. Tonkoglaz, M. V. Lukyanova | ||
| "... values were lower in the “ST” group (p48=0.0035, p96=0.004, p144=0.001). The intergroup differences ..." | ||
| Vol 15, No 3 (2019) | Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko | ||
| "... of the left ventricle lateral wall, on the mitral valve fibrous ring, in the basal segment ..." | ||
| Vol 12, No 5 (2016) | Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis | Abstract similar documents |
| M. V. Klimushina, N. G. Gumanova, A. Ju. Gorshkov, N. E. Gavrilova, V. A. Metel'skaja, S. A. Boytsov | ||
| "... =0.04). Serum endothelin level was 1.8 times lower in men who received statins, compared with men ..." | ||
| Vol 17, No 3 (2021) | The “Inverse” Seasonal Blood Pressure Variability Phenotype | Abstract similar documents |
| V. M. Gorbunov, M. I. Smirnova, Y. N. Koshelyaevskaya, N. N. Panueva, N. V. Furman, P. V. Dolotovskaya | ||
| "... in comparison with the reference group of “minimal” “normal” BPV was 3.07; p=0.004). In summary, inverse BPV ..." | ||
| Vol 4, No 1 (2008) | COMPARISON OF ACE INHIBITOR (FOSINOPRIL) AND Β-ADRENOBLOCKER (ATENOLOL) EFFECTS ON AUTONOMIC REGULATION OF THE HEART IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| A. R. Kiselyov, V. I. Gridnev, O. V. Shevchenko, O. M. Posnenkova, A. N. Strunina, V. A. Schwarz, Ja. P. Dovgalevsky | ||
| "... ) in high-frequency (HF: 0,15-0,4 Hz) and low-frequency (LF: 0,04-0,15 Hz) ranges was calculated as well ..." | ||
| Vol 4, No 3 (2008) | COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov, E. V. Malichenko, E. E. Kazantseva | ||
| "... with enalapril (р=0,04). Brain natriuretic peptide and von Willebrand factor levels decreased more significantly ..." | ||
| Vol 13, No 3 (2017) | EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, O. I. Lukina | ||
| "... in the sacubitril/valsartan group on Day 1 after 6 hours (50%, p=0.004) and subsequent-samples up to 12 hours ..." | ||
| Vol 13, No 6 (2017) | RISK FACTORS OF ARTERIAL HYPERTENSION IN ORGANIZED COHORT OF MALE EMPLOYEES OF THE MACHINE BUILDING PLANT | Abstract similar documents |
| A. N. Britov, S. A. Tjupaeva, N. A. Eliseeva, A. N. Meshkov, A. D. Deev | ||
| "... .3%, respectively; p<0.04), that appears to be evidence of early organ disorders. OF were found more often ..." | ||
| Vol 16, No 4 (2020) | Prevalence and Characteristics of Blood Pressure Phenotypes in Patients with Hypertension and Chronic Respiratory Diseases (Study of Ambulatory Practice Data of a Cardiologist) | Abstract similar documents |
| A. S. Kurekhyan, M. I. Smirnova, V. M. Gorbunov, Ya. N. Koshelyaevskaya, A. D. Deev, M. M. Loukianov | ||
| "... cholesterol (b=0.350, p=0.043), degree of nighttime diastolic BP decrease (for 13.1-18.0% b=-2.130, p=0.004 ..." | ||
| Vol 14, No 2 (2018) | NEPHROPROTECTIVE EFFECTS OF LISINOPRIL IN THE THERAPY OF HYPERTENSIVE PATIENTS WITH OBESITY | Abstract similar documents |
| S. G. Shulkina, Е. N. Smirnova | ||
| "... .3; 60.0] ng/ml (р=0.04) and IL-18 – from 0.33 [0.18; 0.41] to 0.21 [0.14; 0.43] pg/ml (р=0.04). Greater ..." | ||
| Vol 19, No 2 (2023) | Clinical Efficacy and Safety of Empagliflozin in Patients with Acute Heart Failure from the First Day of Hospitalization | Abstract similar documents |
| D. P. Golubovskaya, V. N. Karetnikova, A. B. Osokina, I. P. Oleinik, O. L. Barbarash | ||
| "... fraction (LV EF) (p><0.05). In the comparison group, only an increase in LV ESV was noted (p=0.04 ..." | ||
| Vol 18, No 3 (2022) | Assessment of the Quality of Drug Therapy in Patients with Stable Coronary Artery Disease in the Second Stage of the ALIGN Study | Abstract similar documents |
| E. D. Zharkova, S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, O. M. Drapkina | ||
| "... was found in half of the patients (p=0.004). Conclusion. Despite the initial correction of drug therapy ..." | ||
| Vol 18, No 3 (2022) | Study the Association of Nucleotide Polymorphisms in Platelet Receptor and Cytochrome P450 Genes with the Development of Resistance to Antiplatelet Drugs in Patients with Coronary Artery Disease | Abstract similar documents |
| K. S. Semashchenko, T. S. Mongush, A. A. Kosinova, T. N. Subbotina, Y. I. Grinshtein | ||
| "... to carriers of the T allele (18,49±25,92 vs 10,43±17,34, р=0,004). Conclusion. Polymorphisms of P2RY12 (rs ..." | ||
| Vol 18, No 6 (2022) | Effect of ABCB1 Gene Carriage and Drug-Drug Interactions on Apixaban and Rivaroxaban Pharmacokinetics and Clinical Outcomes in Patients with Atrial Fibrillation and Deep Vein Thrombosis | Abstract similar documents |
| L. V. Fedina, I. N. Sychev, T. D. Rastvorova, E. V. Strigunkova, A. A. Kachanova, Z. A. Sozaeva, P. O. Bochkov, A. V. Vardanyan, K. B. Mirzayev, D. A. Sychev | ||
| "... than those without inhibitors p = 0.004. Conclusion. Our study revealed that the plasma concentration ..." | ||
| Vol 18, No 6 (2022) | Evaluation of Fibrosis Markers as a Potential Method for Diagnosing Non-Obstructive Coronary Artery Disease in Patients with Stable Coronary Artery Disease | Abstract similar documents |
| N. N. Pakhtusov, A. O. Yusupova, K. A. Zhbanov, A. A. Shchedrygina, E. V. Privalova, Yu. N. Belenkov | ||
| "... disease and significantly differed from the main group (p <0.001) and the control group (p=0.04 ..." | ||
| Vol 17, No 3 (2021) | The Effect of Clinical Characteristics and Stent Parameters on Left Ventricular Mechanical Dyssynchrony | Abstract PDF (Eng) similar documents |
| S. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk | ||
| "... .007), dyslipidemia (p=0.001) and stent length (p=0.001), number of stents (p=0.004). There were strong negative ..." | ||
| Vol 12, No 6 (2016) | EFFECT OF AMLODIPINE ON CIRCADIAN RHYTHM OF BLOOD PRESSURE IN HYPERTENSIVE FEMALE PATIENTS WITH DIFFERENT PSYCHO-EMOTIONAL BACKGROUND | Abstract similar documents |
| V. R. Veber, M. P. Rubanova, S. V. Zhmailova, P. M. Gubskaya, A. I. Vinogradov | ||
| "... and from 38.5±10.2 to 95.3±14.7 (p=0.004) in the Group 2. Be- sides increase in load by reduced SBP during ..." | ||
| Vol 12, No 6 (2016) | EFFICIENCY OF INFLUENZA VACCINATION IN PATIENTS WITH CIRCULATORY SYSTEM DISEASES UNDER DISPENSARY OBSERVATION IN OUTPATIENT CLINICS: PROSPECTIVE FOLLOW-UP MONITORING DATA | Abstract similar documents |
| S. A. Boytsov, M. M. Loukianov, E. V. Platonova, V. M. Gorbunov, S. V. Romanchuk, O. A. Nazarova, O. A. Belova, E. A. Kravtsova, P. Ya. Dovgalevsky, N. V. Furman, A. A. Mironova, P. V. Dolotovskaya, A. V. Nekrasov, N. G. Puchkova, M. A. Abramova, E. N. Belova, V. G. Klyashtorny, A. D. Deev | ||
| "... -vaccinated group (28 and 442; р<0.0001). The vaccinated group had fewer CSD worsening cases per patient (p=0.04 ..." | ||
| Vol 5, No 6 (2009) | COMPARATIVE EFFICACY OF AMIODARONE AND BISOPROLOL IN TREATMENT OF VENTRICULAR PREMATURE BEATS IN PATIENTS WITH METABOLIC SYNDROME | Abstract similar documents |
| V. M. Provotorov, M. L. Gluhovsky | ||
| "... because of antiarrhythmic effect loss was also revealed (20.0% vs 46.1%, p=0.004). A number of patients ..." | ||
| Vol 13, No 5 (2017) | RATIONAL PHARMACOTHERAPY IN CARDIOLOGY: FROM ROUTINE CONTROL TO EFFECTIVE MANAGEMENT | Abstract similar documents |
| N. А. Nikolayev, Y. P. Skirdenko, S. S. Bunova, A. V. Ershov | ||
| "... ; p=0.002 at the 150th week; p=0.004 at the 200th week). By the end of the study in the patient ..." | ||
| Vol 6, No 3 (2010) | CLINICAL SIGNIFICANCE OF ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| V. N. Larina, B. Ya. Bart, V. G. Larin | ||
| "... ,041), had diabetes more often (p=0,004, χ2=8,01) in comparison with non anemic patients. Deficiency of iron ..." | ||
| Vol 7, No 5 (2011) | HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko | ||
| "... ) as compared to the control group (RR 0.09; 95%CI 0.01-0.9; p=0.04). Conclusion. Treatment with FA, B and B ..." | ||
| Vol 6, No 5 (2010) | INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract PDF (Eng) similar documents |
| E. N. Golovenko, D. A. Napalkov, V. A. Sulimov | ||
| "... . Mean TrI and myoglobin concentrations equaled 0.04 [0.02; 0.06] ng/ml and 62.95 [35.86; 77.28] μg/l ..." | ||
| Vol 16, No 4 (2020) | Changes in Arterial Wall Stiffness in Patients with Obesity and Paroxysmal Form of Atrial Fibrillation | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, K. K. Osadchiy, R. G. Gataulin, K. A. Oganesyan, N. V. Lobova, Z. B. Jafarova | ||
| "... circumference to hip circumference (WC/HC) ratio and CAVI index (r=0.455, p=0.004); WC/height ratio and CAVI ..." | ||
| Vol 9, No 6 (2013) | THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION) | Abstract similar documents |
| V. A. Sulimov | ||
| "... primary PCI group (1.0% vs 0.2%, p=0.04; after correction protocol and dose reduction by half ..." | ||
| Vol 11, No 5 (2015) | Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease | Abstract similar documents |
| O. A. Rubanenko | ||
| "... .5 pg/ml vs 24.1±14.8 pg/ml, р=0.03; 63.7±54.8 pg/ml vs 50.7±40.8 pg/ml, р=0.04, respectively ..." | ||
| Vol 8, No 2 (2012) | SYNCOPE IN NON-MASSIVE PULMONARY EMBOLISM AS A PREDICTOR OF HIGH-RISK MORTALITY | Abstract similar documents |
| E. A. Kurakina, D. V. Duplyakov, S. M. Khokhlunov, G. S. Kozupitsa | ||
| "... 14.2% in groups 1 and 2, respectively (p=0.004). High risk of death was defined 3 times more often ..." | ||
| Vol 15, No 3 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases | Abstract similar documents |
| E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
| "... with cerebrovascular diseases and a 1.4-fold increase in the risk of ischemic stroke (p=0.004), atheromatosis ..." | ||
| Vol 18, No 1 (2022) | Omega-3 Polyunsaturated Fatty Acids: the Role in Prevention of Atrial Fibrillation in Patients with Coronary Artery Disease after Coronary Artery Bypass Graft Surgery | Abstract PDF (Eng) similar documents |
| O. A. Rubanenko, Yu. V. Shchukin, L. V. Limareva, T. K. Ryazanova, A. O. Rubanenko, I. L. Davydkin | ||
| "... .01) and omega-3 index – 43.4% lower (p=0.04) than in patients of the II group. According to multivariate ..." | ||
| Vol 20, No 2 (2024) | Comparative placebo-controlled study on the effect of dietary supplements containing omega-3 polyunsaturated fatty acids on hemodynamics and lipid metabolism in postmenopausal women | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, A. A. Kudrjavtseva, A. I. Skripka, A. V. Zhilenko, E. V. Kolpachkova, D. K. Varvarina | ||
| "... heart rate according to HM-ECG data by 1.9 beats per minute (p=0.04) in the main group after 3 months ..." | ||
| Vol 20, No 6 (2024) | Сardiac interoception and its link with psychological characteristics in patients with symptomatic and asymptomatic premature ventricular contractions | Abstract similar documents |
| A. S. Limonova, I. A. Minenko, A. A. Sukmanova, K. V. Davtyan, A. I. Ershova, O. M. Drapkina | ||
| "... alexithymia index was elevated in both symptomatic (p=0.004) and asymptomatic patients (p=0.028) compared ..." | ||
| Vol 17, No 4 (2021) | Monitoring of Aspirin Therapy in Patients with Cerebrovascular Pathology | Abstract similar documents |
| M. M. Tanashyan, A. A. Raskurazhev, A. A. Kornilova, A. A. Shabalina, D. A. Abaimov, A. V. Naminov | ||
| "... -induced platelet aggregation with a decrease in the concentration of ASA (p=0.004) and SA (p=0 ..." | ||
| Vol 17, No 4 (2021) | Association of SCN5A gene polymorphism with dilated cardiomyopathy | Abstract similar documents |
| S. Yu. Nikulina, O. O. Kuznetsova, A. A. Chernova, G. V. Matyushin, A. A. Gurazheva, V. N. Maksimov | ||
| "... was statically more common in patients with ICM compared to the control group (11.8% vs. 3.2%, p=0.004). Also ..." | ||
| Vol 18, No 3 (2022) | The Effect of Enhanced External Counterpulsation on the Vascular State, Indicators of Glycemic Control and Quality of Life in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus | Abstract PDF (Eng) similar documents |
| O. A. Slepova, A. S. Lishuta, E. Yu. Vasiltsova, E. V. Privalova, Yu. N. Belenkov | ||
| "... in the HOMA-IR [-9.9% (-26.5; -4.0) vs 7.7% (-7.9; 13.8), p=0.004], as well as in the levels of fasting ..." | ||
| Vol 18, No 5 (2022) | Neuregulin-1β, Biomarkers of Inflammation and Myocardial Fibrosis in Heart Failure Patients | Abstract PDF (Eng) similar documents |
| K. A. Zhbanov, E. Yu. Salakheeva, I. Ya. Sokolova, E. A. Zheleznykh, V. Yu. Zektser, E. V. Privalova, Yu. N. Belenkov, A. A. Shchendrygina | ||
| "... volunteers (р=0.004). There was no difference in NRG-1 concentration between HFpEF and HFrEF. In HF ..." | ||
| Vol 13, No 5 (2017) | INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION | Abstract similar documents |
| E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash | ||
| "... with the ticagrelor group (p=0.04 and p=0.01, respectively). Conclusion. When clopidogrel is replaced with ticagrelor ..." | ||
| Vol 13, No 5 (2017) | COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES | Abstract similar documents |
| A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash | ||
| "... .9% of women and 7.4% of men (p=0.031), while the history of MI was more often found in male patients (p=0.004 ..." | ||
| Vol 13, No 6 (2017) | FACTORS INFLUENCING ON THE MORTALITY IN PATIENTS WITH OBLITERATING DISEASES OF LOWER LIMB ARTERIES | Abstract similar documents |
| A. N. Sumin, M. A. Kosova, Ju. D. Medvedeva, A. V. Shcheglova, O. I. Rajh, S. A. Makarov, G. V. Artamonova, L. S. Barbarash | ||
| "... .031), atherosclerosis of two or more arterial basins ≥50% (OR 3.43, 95% CI 3.46-5.52; p=0.004), the presence ..." | ||
| Vol 7, No 4 (2011) | PROTHROMBOTIC POLYMORPHISMS AND LONG-TERM PROGNOSIS OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. L. Komarov, O. O. Shahmatova, D. V. Rebrikov, D. Yu. Trophimov, T. I. Kotkina, T. A. Ilyushenko, A. D. Deev, E. P. Panchenko | ||
| "... .63 times (95% CI 1.2-2.3, р=0.006) and 1.37 times (95% CI 1.001-1.89, р=0.04), respectively. Such genetic ..." | ||
| Vol 6, No 6 (2010) | HEART REMODELING AT DIFFERENT STAGES OF CHRONIC HEART FAILURE IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND DILATED CARDIOMYOPATHY | Abstract similar documents |
| V. V. Mazur, A. M. Kalinkin, E. S. Mazur | ||
| "... at any CHF stage in PICS patients was significantly higher than this in DCM patients (1.48±0.04 and 1 ..." | ||
| Vol 16, No 2 (2020) | The Effect of Pharmacological Preconditioning with Nicorandil before Elective Coronary Stenting on the Long-Term Prognosis of Patients with Stable Coronary Artery Disease | Abstract similar documents |
| G. N. Soboleva, R. V. Gostishchev, A. N. Rogoza, T. I. Kotkina, A. N. Samko, Yu. A. Karpov | ||
| "... with cutting value 389.8 pg/ml, AUC=0.641 (p=0.04). Сonclusion. Peroral nicorandil 30 mg/day 2 days before PCI ..." | ||
| Vol 16, No 3 (2020) | A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study | Abstract similar documents |
| N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey | ||
| "... of the study (7.9%, 9.1% and 20.5% respectively; p=0.04 for the latter). The thromboxane B2 level by the 3rd ..." | ||
| Vol 16, No 4 (2020) | Optimization of a Comprehensive Prehabilitation Program for Patients with Stable Coronary Artery Disease Undergoing Elective Coronary Artery Bypass Grafting | Abstract PDF (Eng) similar documents |
| Yu. A. Argunova, T. N. Zvereva, S. A. Pomeshkina, A. V. Ivanova, O. M. Polikutina, O. V. Gruzdeva, V. V. Kashtalap, O. L. Barbarash | ||
| "... in the control group (p=0.04). Group 1 patients reported longer distance covered in 6MWT than Group 2 patients ..." | ||
| 1 - 100 of 129 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
